chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Chest pain, Nausea, Pruritus, Rash
Clinical narrative: Severe Nausea; abdomen pass occurred within 10-15 min had diarrhea for a couple days after injection; This is a spontaneous report from a contactable consumer. This consumer (patient) reported in response to HCP letter via follow-up letter which included that:  A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EK9231, Expiration date was not reported), dose 2 intramuscular, administered in Deltoid Right on 14Jan2021 11:00 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection)dose 1 on 23Dec2020 (age at vaccination 44 years) for covid-19 immunization experienced events Shortness of breath/ Difficulty in breathing (without wheeze or stridor), After about 15 Mins got a scratch rash on my arm that spread over the hour across my back and chest, Increased heart rate, Increased heart rate and blood pressure, GI upset, Tightness in chest, Respiratory distress, Increased use of accessory respiratory muscles, Tachycardia, Diarrhea, Vomiting, fluttering in chest, Generalized erythema, Generalized pruritus with skin rash, Generalized prickle sensation, Localized injection site urticaria, Nausea, Abdominal pain. On an unspecified date the patient experienced severe nausea, abdomen pass occurred within 10-15 min had diarrhea for a couple days after injection. The outcome of event was unknown.   Follow-up attempts are needed. Further information is requested.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Nausea
Clinical narrative: Severe Nausea; abdomen pass occurred within 10-15 min had diarrhea for a couple days after injection; This is a spontaneous report from a contactable consumer. This consumer (patient) reported in response to HCP letter via follow-up letter which included that:  A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EK9231, Expiration date was not reported), dose 2 intramuscular, administered in Deltoid Right on 14Jan2021 11:00 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection)dose 1 on 23Dec2020 (age at vaccination 44 years) for covid-19 immunization experienced events Shortness of breath/ Difficulty in breathing (without wheeze or stridor), After about 15 Mins got a scratch rash on my arm that spread over the hour across my back and chest, Increased heart rate, Increased heart rate and blood pressure, GI upset, Tightness in chest, Respiratory distress, Increased use of accessory respiratory muscles, Tachycardia, Diarrhea, Vomiting, fluttering in chest, Generalized erythema, Generalized pruritus with skin rash, Generalized prickle sensation, Localized injection site urticaria, Nausea, Abdominal pain. On an unspecified date the patient experienced severe nausea, abdomen pass occurred within 10-15 min had diarrhea for a couple days after injection. The outcome of event was unknown.   Follow-up attempts are needed. Further information is requested.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, Cardiomyopathy, Catheterisation cardiac abnormal, Chest pain, Chills
Clinical narrative: I had Covid-19 in January of 2021. I had mild symptoms. One day after the first dose of my vaccine I had Arrhythmia. I went the ER, and I was admitted for an Angiogram. I was transferred to the Medical Center. I was in the ICU for 3 days. I was transferred to Telemetry for 3 more days. I was discharged and I returned 2 days later because I had Arrhythmia. I was having chest pain and my White Cells were very high. I was in Telemetry for 4 days. I went back to work until a Few days after the second dose when I was hospitalized again.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram abnormal, Ejection fraction, Electrocardiogram abnormal, Electrocardiogram normal, Headache
Clinical narrative: I had Covid-19 in January of 2021. I had mild symptoms. One day after the first dose of my vaccine I had Arrhythmia. I went the ER, and I was admitted for an Angiogram. I was transferred to the Medical Center. I was in the ICU for 3 days. I was transferred to Telemetry for 3 more days. I was discharged and I returned 2 days later because I had Arrhythmia. I was having chest pain and my White Cells were very high. I was in Telemetry for 4 days. I went back to work until a Few days after the second dose when I was hospitalized again.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: I had Covid-19 in January of 2021. I had mild symptoms. One day after the first dose of my vaccine I had Arrhythmia. I went the ER, and I was admitted for an Angiogram. I was transferred to the Medical Center. I was in the ICU for 3 days. I was transferred to Telemetry for 3 more days. I was discharged and I returned 2 days later because I had Arrhythmia. I was having chest pain and my White Cells were very high. I was in Telemetry for 4 days. I went back to work until a Few days after the second dose when I was hospitalized again.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Arrhythmia, Cardiac telemetry, Chest pain, Impaired work ability
Clinical narrative: I had Covid-19 in January of 2021. I had mild symptoms. One day after the first dose of my vaccine I had Arrhythmia. I went the ER, and I was admitted for an Angiogram. I was transferred to the Medical Center. I was in the ICU for 3 days. I was transferred to Telemetry for 3 more days. I was discharged and I returned 2 days later because I had Arrhythmia. I was having chest pain and my White Cells were very high. I was in Telemetry for 4 days. I went back to work until a Few days after the second dose when I was hospitalized again.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Intensive care, White blood cell count increased
Clinical narrative: I had Covid-19 in January of 2021. I had mild symptoms. One day after the first dose of my vaccine I had Arrhythmia. I went the ER, and I was admitted for an Angiogram. I was transferred to the Medical Center. I was in the ICU for 3 days. I was transferred to Telemetry for 3 more days. I was discharged and I returned 2 days later because I had Arrhythmia. I was having chest pain and my White Cells were very high. I was in Telemetry for 4 days. I went back to work until a Few days after the second dose when I was hospitalized again.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site pain, Paraesthesia oral
Clinical narrative: Tingling around lips; Soreness at vaccination site; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 12Mar2021 at 14:00(at the age of 43-years-old), as a single dose for COVID-19 immunisation. Medical history included pulmonary embolism (3 years ago), pre-diabetes and seasonal allergy. The patient had no known allergy to food or medicines. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) for allergy from unknown date and unspecified multivitamins for unknown indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Mar2021, about 45 minutes after the vaccine, at 14:45 the patient experienced tingling around lips that lasted about half an hour. On 12Mar2021 at 14:45 the patient experienced soreness at vaccination site the next two days. (The day of was fine). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event tingling around lips was recovered on 12Mar2021 at 14:45. The clinical outcome of the event vaccination site pain was recovered on 14Mar2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia oral, Vaccination site pain
Clinical narrative: Tingling around lips; Soreness at vaccination site; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 12Mar2021 at 14:00(at the age of 43-years-old), as a single dose for COVID-19 immunisation. Medical history included pulmonary embolism (3 years ago), pre-diabetes and seasonal allergy. The patient had no known allergy to food or medicines. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) for allergy from unknown date and unspecified multivitamins for unknown indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Mar2021, about 45 minutes after the vaccine, at 14:45 the patient experienced tingling around lips that lasted about half an hour. On 12Mar2021 at 14:45 the patient experienced soreness at vaccination site the next two days. (The day of was fine). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event tingling around lips was recovered on 12Mar2021 at 14:45. The clinical outcome of the event vaccination site pain was recovered on 14Mar2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Dizziness, Impaired driving ability, Rhinorrhoea, Wheezing
Clinical narrative: Extreme dizziness, wheezing, runny nose, and joint pain; Wheezing; Runny nose; Joint pain; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 01Apr2021 at 17:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis. The patient was allergic to onions. Concomitant medications included atenolol (MANUFACTURER UNKNOWN) for unknown indication from unknown date taken within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 18:00 the patient experienced extreme dizziness, wheezing, runny nose, and joint pain. The patient did not receive any treatment for the events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events extreme dizziness, wheezing, runny nose, and joint pain was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Dizziness, Rhinorrhoea, Wheezing
Clinical narrative: Extreme dizziness, wheezing, runny nose, and joint pain; Wheezing; Runny nose; Joint pain; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 01Apr2021 at 17:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis. The patient was allergic to onions. Concomitant medications included atenolol (MANUFACTURER UNKNOWN) for unknown indication from unknown date taken within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 18:00 the patient experienced extreme dizziness, wheezing, runny nose, and joint pain. The patient did not receive any treatment for the events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events extreme dizziness, wheezing, runny nose, and joint pain was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Menstrual disorder
Clinical narrative: Menstruating about 10 days early; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 31Mar2021 at 15:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD) and asthma. The patient had seasonal plant allergies (ragweed, etc.). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included duloxetine (MANUFACTURER UNKNOWN), amfetamine aspartate; amfetamine sulfate; dexamfetamine saccharate; dexamfetamine sulfate (ADDERALL XR) and prenatal Vitamins (unspecified). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021, the patient experienced menstruating about 10 days early. It was reported that the patient started menstruating about 10 days early, on day 20 of her cycle. The patient was currently (at the time this report) trying to conceive and was worried that this may have disrupted implantation. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event menstruating about 10 days early was unknown at the time this report.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Menstruation irregular
Clinical narrative: Menstruating about 10 days early; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 31Mar2021 at 15:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD) and asthma. The patient had seasonal plant allergies (ragweed, etc.). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included duloxetine (MANUFACTURER UNKNOWN), amfetamine aspartate; amfetamine sulfate; dexamfetamine saccharate; dexamfetamine sulfate (ADDERALL XR) and prenatal Vitamins (unspecified). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021, the patient experienced menstruating about 10 days early. It was reported that the patient started menstruating about 10 days early, on day 20 of her cycle. The patient was currently (at the time this report) trying to conceive and was worried that this may have disrupted implantation. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event menstruating about 10 days early was unknown at the time this report.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Exposure during pregnancy, Fatigue, Hyperhidrosis, Pain in extremity
Clinical narrative: Gestational period : 29 weeks; hot flashes; chills; tired; sore arm; headache; Couldn't stay awake; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EN6207) via an unspecified route of administration in the left arm on 12Mar2021 at 14:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included pregnancy (29-weeks at the time of vaccination). The patient did not have any allergies to medications, food, or other products. Concomitant medications included sertraline hydrochloride (ZOLOFT) since an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Mar2021 the patient experienced sore arm, tiredness, chills, sleepiness, hot flushes and headache. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of sore arm, tired, chills, sleepiness, hot flushes and headache were recovered on 15Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Hot flush, Maternal exposure during pregnancy
Clinical narrative: Gestational period : 29 weeks; hot flashes; chills; tired; sore arm; headache; Couldn't stay awake; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EN6207) via an unspecified route of administration in the left arm on 12Mar2021 at 14:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included pregnancy (29-weeks at the time of vaccination). The patient did not have any allergies to medications, food, or other products. Concomitant medications included sertraline hydrochloride (ZOLOFT) since an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Mar2021 the patient experienced sore arm, tiredness, chills, sleepiness, hot flushes and headache. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of sore arm, tired, chills, sleepiness, hot flushes and headache were recovered on 15Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Somnolence
Clinical narrative: Gestational period : 29 weeks; hot flashes; chills; tired; sore arm; headache; Couldn't stay awake; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EN6207) via an unspecified route of administration in the left arm on 12Mar2021 at 14:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included pregnancy (29-weeks at the time of vaccination). The patient did not have any allergies to medications, food, or other products. Concomitant medications included sertraline hydrochloride (ZOLOFT) since an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Mar2021 the patient experienced sore arm, tiredness, chills, sleepiness, hot flushes and headache. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of sore arm, tired, chills, sleepiness, hot flushes and headache were recovered on 15Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes in underarm; This is a spontaneous report from a contactable consumer, the patient. A 55-years-old male patient received unspecified dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 20Mar2021 at 12:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa antibiotics, Hornets, Yellow Jackets, mold, Ragweed, Yeast, Hops, Chocolate, Kiwi fruit. Patient received other medications in two weeks which included methscscop/Phenylep (MANAFACTURER UNKNOWN) 2.5/20 from an unspecified date for allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021 at 15:00 the patient experienced Swollen lymph nodes in underarm of arm where vaccine was given. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Clinical outcome of swollen lymph nodes was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Feeling abnormal, Heart rate increased, Hyperhidrosis, Injection site pain
Clinical narrative: a low fever or slightly elevated temperature; woke up in a sweat; fast heartbeat; head was fuzzy; no energy; extremely tired; slight muscle pain; injection site pain; arm stiffness; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 31Mar2021 at 16:00(at the age of 29-years-old), as a single dose for COVID-19 immunisation. Medical history included ADHD, anxiety, moderate depression and outdoor allergy. Concomitant medications included atomoxetine hydrochloride (STRATTERA), desvenlafaxine succinate (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA) and acetylcysteine (NAC) and vita (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 the patient experienced arm stiffness and injection site pain. On 01Apr2021 at 02:00 the patient experienced fast heartbeat. The patient thought it as a possible severe allergic reaction but had no other symptoms at that time other than pain and stiffness, so went back to sleep. On 01Apr2021 at 11:00 the patient woke up in a sweat. The patient was not sure if had a fever at all during the night. On 01Apr2021 at 22:00, the patient experienced a low fever or slightly elevated temperature. On 01Apr2021 the patient experienced head was fuzzy, no energy, extremely tired and slight muscle pain. On 01Apr2021, the patient underwent lab tests and procedures which included body temperature and the result was 99.9 degrees Fahrenheit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the event stiffness, vaccination site pain, fast heartbeat, sweaty, fever, fuzzy, loss of energy, tiredness and muscle pain was recovered on 02Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Musculoskeletal stiffness, Myalgia
Clinical narrative: a low fever or slightly elevated temperature; woke up in a sweat; fast heartbeat; head was fuzzy; no energy; extremely tired; slight muscle pain; injection site pain; arm stiffness; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 31Mar2021 at 16:00(at the age of 29-years-old), as a single dose for COVID-19 immunisation. Medical history included ADHD, anxiety, moderate depression and outdoor allergy. Concomitant medications included atomoxetine hydrochloride (STRATTERA), desvenlafaxine succinate (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA) and acetylcysteine (NAC) and vita (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 the patient experienced arm stiffness and injection site pain. On 01Apr2021 at 02:00 the patient experienced fast heartbeat. The patient thought it as a possible severe allergic reaction but had no other symptoms at that time other than pain and stiffness, so went back to sleep. On 01Apr2021 at 11:00 the patient woke up in a sweat. The patient was not sure if had a fever at all during the night. On 01Apr2021 at 22:00, the patient experienced a low fever or slightly elevated temperature. On 01Apr2021 the patient experienced head was fuzzy, no energy, extremely tired and slight muscle pain. On 01Apr2021, the patient underwent lab tests and procedures which included body temperature and the result was 99.9 degrees Fahrenheit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the event stiffness, vaccination site pain, fast heartbeat, sweaty, fever, fuzzy, loss of energy, tiredness and muscle pain was recovered on 02Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Body temperature, Fatigue, Feeling abnormal, Heart rate increased
Clinical narrative: a low fever or slightly elevated temperature; woke up in a sweat; fast heartbeat; head was fuzzy; no energy; extremely tired; slight muscle pain; injection site pain; arm stiffness; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 31Mar2021 at 16:00(at the age of 29-years-old), as a single dose for COVID-19 immunisation. Medical history included ADHD, anxiety, moderate depression and outdoor allergy. Concomitant medications included atomoxetine hydrochloride (STRATTERA), desvenlafaxine succinate (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA) and acetylcysteine (NAC) and vita (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 the patient experienced arm stiffness and injection site pain. On 01Apr2021 at 02:00 the patient experienced fast heartbeat. The patient thought it as a possible severe allergic reaction but had no other symptoms at that time other than pain and stiffness, so went back to sleep. On 01Apr2021 at 11:00 the patient woke up in a sweat. The patient was not sure if had a fever at all during the night. On 01Apr2021 at 22:00, the patient experienced a low fever or slightly elevated temperature. On 01Apr2021 the patient experienced head was fuzzy, no energy, extremely tired and slight muscle pain. On 01Apr2021, the patient underwent lab tests and procedures which included body temperature and the result was 99.9 degrees Fahrenheit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the event stiffness, vaccination site pain, fast heartbeat, sweaty, fever, fuzzy, loss of energy, tiredness and muscle pain was recovered on 02Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Musculoskeletal stiffness, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: a low fever or slightly elevated temperature; woke up in a sweat; fast heartbeat; head was fuzzy; no energy; extremely tired; slight muscle pain; injection site pain; arm stiffness; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 31Mar2021 at 16:00(at the age of 29-years-old), as a single dose for COVID-19 immunisation. Medical history included ADHD, anxiety, moderate depression and outdoor allergy. Concomitant medications included atomoxetine hydrochloride (STRATTERA), desvenlafaxine succinate (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA) and acetylcysteine (NAC) and vita (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 the patient experienced arm stiffness and injection site pain. On 01Apr2021 at 02:00 the patient experienced fast heartbeat. The patient thought it as a possible severe allergic reaction but had no other symptoms at that time other than pain and stiffness, so went back to sleep. On 01Apr2021 at 11:00 the patient woke up in a sweat. The patient was not sure if had a fever at all during the night. On 01Apr2021 at 22:00, the patient experienced a low fever or slightly elevated temperature. On 01Apr2021 the patient experienced head was fuzzy, no energy, extremely tired and slight muscle pain. On 01Apr2021, the patient underwent lab tests and procedures which included body temperature and the result was 99.9 degrees Fahrenheit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the event stiffness, vaccination site pain, fast heartbeat, sweaty, fever, fuzzy, loss of energy, tiredness and muscle pain was recovered on 02Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Burning sensation, Chest pain, Grip strength decreased, Hemiparesis
Clinical narrative: Day 14 sharp shooting pain left back; Day 13 weakness with workout/grip; Day 12 decreased sensation; Tingling left shoulder; Day 9-10 finger pain, chest pain (right side); Day 6 leg pain, numb, tingly; burning spot on leg; Day 3 tingling lips, hand; middle finger pain; Day 1 sore arm 24 hrs; Day 0 day of vaccine tingling hand post injection; This is a spontaneous report from a contactable healthcare professional, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204), via an unspecified route of administration in the arm left on 19Mar2021 at 14:45 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history included latex allergy and sulfonamide allergy. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 at 14:45, the patient experienced tingling hand post injection. On 20Mar2021, the patient experienced sore arm 24 hrs. On 21Mar2021, the patient did not experience anything. On 22Mar2021, the patient experienced tingling lips, hand and middle finger pain. On 23Mar2021, the patient experienced middle finger pain, tingling and burning spot on leg. On 24Mar2021, the patient did not experience anything. On 25Mar2021, the patient experienced leg pain, numb, tingly. On 26Mar2021, the patient experienced finger pain. On 28Mar2021, the patient experienced finger pain, chest pain (right side). On 30Mar2021, the patient experienced tingling left shoulder. On 31Mar2021, the patient experienced decreased sensation. On 01Apr2021, the patient experienced weakness with workout or grip. On 02Apr2021, the patient experienced sharp shooting pain left back. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events  tingling hand post injection, sore arm, tingling lips, hand, middle finger pain tingling/burning spot on leg, leg pain, numb, tingly, finger pain, chest pain (right side), tingling left shoulder, decreased sensation, weakness with workout or grip and sharp shooting pain left back were not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Pain, Pain in extremity, Paraesthesia, Paraesthesia oral
Clinical narrative: Day 14 sharp shooting pain left back; Day 13 weakness with workout/grip; Day 12 decreased sensation; Tingling left shoulder; Day 9-10 finger pain, chest pain (right side); Day 6 leg pain, numb, tingly; burning spot on leg; Day 3 tingling lips, hand; middle finger pain; Day 1 sore arm 24 hrs; Day 0 day of vaccine tingling hand post injection; This is a spontaneous report from a contactable healthcare professional, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204), via an unspecified route of administration in the arm left on 19Mar2021 at 14:45 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history included latex allergy and sulfonamide allergy. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 at 14:45, the patient experienced tingling hand post injection. On 20Mar2021, the patient experienced sore arm 24 hrs. On 21Mar2021, the patient did not experience anything. On 22Mar2021, the patient experienced tingling lips, hand and middle finger pain. On 23Mar2021, the patient experienced middle finger pain, tingling and burning spot on leg. On 24Mar2021, the patient did not experience anything. On 25Mar2021, the patient experienced leg pain, numb, tingly. On 26Mar2021, the patient experienced finger pain. On 28Mar2021, the patient experienced finger pain, chest pain (right side). On 30Mar2021, the patient experienced tingling left shoulder. On 31Mar2021, the patient experienced decreased sensation. On 01Apr2021, the patient experienced weakness with workout or grip. On 02Apr2021, the patient experienced sharp shooting pain left back. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events  tingling hand post injection, sore arm, tingling lips, hand, middle finger pain tingling/burning spot on leg, leg pain, numb, tingly, finger pain, chest pain (right side), tingling left shoulder, decreased sensation, weakness with workout or grip and sharp shooting pain left back were not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Back pain, Burning sensation, Chest pain, Hypoaesthesia
Clinical narrative: Day 14 sharp shooting pain left back; Day 13 weakness with workout/grip; Day 12 decreased sensation; Tingling left shoulder; Day 9-10 finger pain, chest pain (right side); Day 6 leg pain, numb, tingly; burning spot on leg; Day 3 tingling lips, hand; middle finger pain; Day 1 sore arm 24 hrs; Day 0 day of vaccine tingling hand post injection; This is a spontaneous report from a contactable healthcare professional, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204), via an unspecified route of administration in the arm left on 19Mar2021 at 14:45 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history included latex allergy and sulfonamide allergy. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 at 14:45, the patient experienced tingling hand post injection. On 20Mar2021, the patient experienced sore arm 24 hrs. On 21Mar2021, the patient did not experience anything. On 22Mar2021, the patient experienced tingling lips, hand and middle finger pain. On 23Mar2021, the patient experienced middle finger pain, tingling and burning spot on leg. On 24Mar2021, the patient did not experience anything. On 25Mar2021, the patient experienced leg pain, numb, tingly. On 26Mar2021, the patient experienced finger pain. On 28Mar2021, the patient experienced finger pain, chest pain (right side). On 30Mar2021, the patient experienced tingling left shoulder. On 31Mar2021, the patient experienced decreased sensation. On 01Apr2021, the patient experienced weakness with workout or grip. On 02Apr2021, the patient experienced sharp shooting pain left back. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events  tingling hand post injection, sore arm, tingling lips, hand, middle finger pain tingling/burning spot on leg, leg pain, numb, tingly, finger pain, chest pain (right side), tingling left shoulder, decreased sensation, weakness with workout or grip and sharp shooting pain left back were not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Paraesthesia, Paraesthesia oral, Sensitisation
Clinical narrative: Day 14 sharp shooting pain left back; Day 13 weakness with workout/grip; Day 12 decreased sensation; Tingling left shoulder; Day 9-10 finger pain, chest pain (right side); Day 6 leg pain, numb, tingly; burning spot on leg; Day 3 tingling lips, hand; middle finger pain; Day 1 sore arm 24 hrs; Day 0 day of vaccine tingling hand post injection; This is a spontaneous report from a contactable healthcare professional, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204), via an unspecified route of administration in the arm left on 19Mar2021 at 14:45 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history included latex allergy and sulfonamide allergy. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 at 14:45, the patient experienced tingling hand post injection. On 20Mar2021, the patient experienced sore arm 24 hrs. On 21Mar2021, the patient did not experience anything. On 22Mar2021, the patient experienced tingling lips, hand and middle finger pain. On 23Mar2021, the patient experienced middle finger pain, tingling and burning spot on leg. On 24Mar2021, the patient did not experience anything. On 25Mar2021, the patient experienced leg pain, numb, tingly. On 26Mar2021, the patient experienced finger pain. On 28Mar2021, the patient experienced finger pain, chest pain (right side). On 30Mar2021, the patient experienced tingling left shoulder. On 31Mar2021, the patient experienced decreased sensation. On 01Apr2021, the patient experienced weakness with workout or grip. On 02Apr2021, the patient experienced sharp shooting pain left back. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events  tingling hand post injection, sore arm, tingling lips, hand, middle finger pain tingling/burning spot on leg, leg pain, numb, tingly, finger pain, chest pain (right side), tingling left shoulder, decreased sensation, weakness with workout or grip and sharp shooting pain left back were not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations, Swollen tongue
Clinical narrative: felt weird; sore throat; cold like symptoms; tongue swole up; heart racing fast; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: unknown) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 13:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity and high cholesterol. The patient had history of known allergies to shellfish, grass, some beans, fur animals and just about everything. Concomitant medications included montelukast sodium (SINGULAIR), cetirizine hydrochloride (ZYRTEC), simvastatin (MANUFACTURER UNKNOWN) and vitamins, all from unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in Apr2021 at 13:00, the patient experienced felt weird, like a sore throat out of no where, cold like symptoms and then on that later evening tongue swole up and her heart was racing fast. The patient underwent lab tests and procedures, which included COVID test on an unknown date, which result was unknown. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events and included treatment with diphenhydramine (BENADRYL). The clinical outcomes of felt weird, sore throat, cold like symptoms, tongue swole up and heart racing fast were unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Feeling abnormal, Nasopharyngitis, Oropharyngeal pain, Palpitations
Clinical narrative: felt weird; sore throat; cold like symptoms; tongue swole up; heart racing fast; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: unknown) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 13:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity and high cholesterol. The patient had history of known allergies to shellfish, grass, some beans, fur animals and just about everything. Concomitant medications included montelukast sodium (SINGULAIR), cetirizine hydrochloride (ZYRTEC), simvastatin (MANUFACTURER UNKNOWN) and vitamins, all from unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in Apr2021 at 13:00, the patient experienced felt weird, like a sore throat out of no where, cold like symptoms and then on that later evening tongue swole up and her heart was racing fast. The patient underwent lab tests and procedures, which included COVID test on an unknown date, which result was unknown. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events and included treatment with diphenhydramine (BENADRYL). The clinical outcomes of felt weird, sore throat, cold like symptoms, tongue swole up and heart racing fast were unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.